Ilaris subcutaneous injection 150mg, manufactured by Novartis Pharma, contains canakinumab (genetical recombination). This product is used to treat various autoinflammatory periodic fever syndromes, active Still’s disease, and gout flares. It is a 150mg 1mL 1 bottle with YJ code 3999434A1026.
Ilaris subcutaneous injection 150mg
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →